Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Northern-Manhattan Hispanic Caregiver Intervention Effectiveness Study (NHiCE)

8 de julio de 2021 actualizado por: José A. Luchsinger, Columbia University

The primary research question is which of the 2 best known dementia caregiver interventions, the New York University Caregiver intervention (NYUCI) and Resources for Enhancing Caregivers Health Offering Useful Treatments (REACH OUT), is more effective in alleviating depressive symptoms and caregiver burden among Hispanic caregivers in New York City. The investigators hypothesize that the NYUCI will be more effective than REACH OUT in reducing caregiver depressive symptoms and burden among Hispanics because of its focus on family-centered counseling, which is posited to be more important among Hispanic caregivers because of a cultural emphasis among Hispanics on family interactions in interventions. In order to answer the primary question, the investigators will conduct a pragmatic randomized trial comparing the NYUCI vs. REACH OUT in 200 Hispanic caregivers of persons with dementia in the community of Northern Manhattan. The total time of the intervention will be 6 months.

Our research question is which intervention, NYUCI or REACH OUT, is better in Hispanic relative (any relative) caregivers of persons with dementia. Our objective is to obtain effectiveness information that will help caregivers and health providers to make decisions about which intervention to choose. Our primary aim is to compare the effectiveness of the implementation of the NYUCI and REACH OUT in reducing depressive symptoms and burden. Our exploratory aims are to examine and compare the predictors of effectiveness of the NYUCI and REACH OUT and to examine additional outcomes such as caregiver stress and physical health, and outcomes related to the person with dementia. METHODS. We will conduct a pragmatic randomized trial of 200 relative caregivers of persons with dementia. Participants will be randomized to the NYUCI or REACH OUT. The total duration of the intervention will be 6 months, with assessments at baseline and follow-up. All interventions and questionnaires will be conducted in both English and Spanish. The study duration will be 3 years. The primary outcomes will be changes in caregiver depressive symptoms, measured with the Geriatric Depression Scale, and in caregiver burden using the Zarit caregiver burden interview.

Descripción general del estudio

Descripción detallada

The prevalence of dementia is increasing with the aging of the population and the absence of prevention or cure. Thus, the burden of dementia on caregivers is also increasing. Hispanics have a higher prevalence of dementia than non-Hispanic Whites (NHW), have higher caregiving burden, and may have less economic resources to cope with the caregiving burden. However, there is a paucity of evidence on the effectiveness of caregiver interventions in Hispanics. We propose to compare 2 interventions with evidence of efficacy, the New York University Caregiver intervention (NYUCI) and the translated Resources for Enhancing Caregivers Health Offering Useful Treatments (REACH OUT). The NYUCI is a family centered counseling intervention that focuses on reducing negative family interactions and improving family support of the primary caregiver. REACH OUT focuses on caregiver skills training through action-oriented formal problem solving, goal setting, and written action plans. The effectiveness of the NYUCI and the REACH OUT has never been compared. Thus, there is no way for caregivers to decide which intervention to choose. In addition, there is a paucity of data on the effectiveness of both interventions in Hispanics.

Tipo de estudio

Intervencionista

Inscripción (Actual)

221

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • New York
      • New York, New York, Estados Unidos, 10032
        • Columbia University Medical Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 90 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Self identified Hispanic
  • Between the ages of 18 and 90.
  • Caregiver is related to persons receiving care either as a spouse (including common law partners) or a blood or in-law relative.
  • Person receiving care has been diagnosed with dementia and reports at least 1 memory/cognition and 1 daily functioning symptom in our screening questionnaire (see appendix).
  • Caregiver is physically able to provide care
  • Caregiver does not have a diagnosis of major psychiatric disorder other than depression.
  • Caregiver does not have depression with psychotic features or suicidal ideation or attempts in the last 5 years.
  • Caregiver is expected to live in New York City in the next 6 months or is available for study procedures in the New York City area.
  • There is at least one relative or close friend living in the New York City Metropolitan Area (New York, New Jersey, Connecticut).

Exclusion Criteria:

  • Not Hispanic
  • Caregiver is not a relative as defined in the inclusion criteria.
  • Person receiving care does not have dementia
  • Other than depression, caregiver has a major psychiatric disorder such as schizophrenia
  • Caregiver has depression with psychotic features or suicidal ideation in the last 5 years.
  • Severe depression defined by a Patient Health Questionnaire (PHQ)-9 > 20.
  • Previous or current participation in caregiver support programs with the NYUCI or the REACH OUT

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: NYU Caregiver Intervention
The New York University (NYU) caregiver intervention arm received the NYU caregiver intervention in addition to social work support and educational materials.
All study participants were provided access to social support services at Riverstone Senior Life services
All participants received educational material about dementia and caregiving in addition to information about resources for persons with dementia and their caregivers, including resources at the Alzheimer's Association such as support groups, and clinical and service resources available citywide.
The first component consists of 2 individual and 4 family counseling sessions. These sessions last between 1 and 1.5 hours. The second component of the intervention is participation in a caregiver support group . The third component of the treatment is "ad hoc" counseling. New psychiatric and behavioral problems of patients, which are generally more stressful than the need for assistance with activities of daily living or physical limitations, often precipitate ad hoc calls from caregivers.
Comparador activo: REACH OUT
The Resources for Enhancing Caregiver Health Offering Useful Treatments (REACH OUT) intervention arm received the REACH OUT caregiver intervention in addition to social work support and educational materials.
All study participants were provided access to social support services at Riverstone Senior Life services
All participants received educational material about dementia and caregiving in addition to information about resources for persons with dementia and their caregivers, including resources at the Alzheimer's Association such as support groups, and clinical and service resources available citywide.
All aspects of the REACH OUT Intervention involve problem solving techniques and the development of written action plans. The goal of this intervention is to engage the caregiver in joint problem-solving with the objective of creating a written action plan targeting specific caregiving problems. The basic steps of problem solving are: 1.Define the problem. 2. Set goals 3. Brainstorm with caregiver and List possible solutions on a pad of paper, 4. Select solutions, 5. Develop an action plan based on these solutions, 6. Implement the action plan, track progress, and make adjustments as needed

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Score on Geriatric Depression Scale
Periodo de tiempo: 6 months
The Geriatric Depression Scale (GDS) is a 30-item self-report assessment used to identify depression in the elderly. The GDS questions are answered "yes" or "no", instead of a five-category response set. One point is assigned to each answer and the cumulative score is rated on a scoring grid. The grid sets a range of 0-9 as "normal", 10-19 as "mildly depressed", and 20-30 as "severely depressed".Higher scores indicate more depressive symptoms.
6 months
Score on Zarit Caregiver Burden Scale
Periodo de tiempo: 6 months
Zarit Caregiver Burden Scale measures caregiver burden by asking caregivers to respond to a series of 22 questions about the impact of the patient's disabilities on their life. For each item, caregivers are to indicate how often they felt that way (never, rarely, sometimes, quite frequently, or nearly always). The Burden Interview is scored by adding the numbered responses of the individual items. Higher scores indicate greater caregiver distress. Estimates of the degree of burden can be made from preliminary findings: 0 - 20 (little or no burden), 21 - 40 (mild to moderate burden), 41 - 60 (moderate to severe burden), and 61 - 88 (severe burden).
6 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Score on Patient Reported Outcomes Measurement Information System (PROMIS) Physical Health Scale
Periodo de tiempo: 6 months
The Patient Reported Outcomes Measurement Information System (PROMIS) Physical Health Scale: For adults, each question has five response options ranging in value from one to five (for pediatrics and parent proxy it is 0 to 4). To find the total raw score for a short form with all questions answered, sum the values of the response to each question. For example, for the adult 10-item form, the lowest possible raw score is 10; the highest possible raw score is 50. T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points. A high score always represents more of the concept being measured. Higher scores indicate better health.
6 months
Score on Perceived Stress Scale (PSS)
Periodo de tiempo: 6 months
The Perceived Stress Scale is a self-report measure of stress that would be used to measure caregiver stress. The total score is calculated by finding the sum of 10 items, reverse coding questions 4, 5, 7, & 8. The PSS has a range of scores between 0 and 40. A higher score indicates more stress.
6 months
Score on the PROMIS Short Form (SF) Depression Scale
Periodo de tiempo: 6 months
Depressive symptoms measured with the PROMIS SF Depression Scale: Each question has five response options ranging in value from one to five. To find the total raw score, sum the values of the response to each question. For example, for the eight-item form, the lowest possible raw score is 8; the highest possible raw score is 40. The total raw score is then converted into a T-score for each participant. The T-score rescales the raw score into a standardized score with a mean of 50 and a standard deviation (SD) of 10. A higher score means more depressive symptoms.
6 months
Total Score on Patient Health Questionnaire (PHQ-9)
Periodo de tiempo: 6 months
The PHQ-9 is the depression module, which scores each of the 9 Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria as "0" (not at all) to "3" (nearly every day). PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. The range of the total score of the PHQ-9 is 0 to 27, with higher scores indicating more depressive symptoms.
6 months

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Score on the Lawton Caregiving Appraisal Scale (CAS) - Burden Subscale
Periodo de tiempo: 6 months
The Lawton Caregiver Appraisal Scale burden subscale has 9 items. Items include "Do you feel that because of the time you spend with your Elder that you don't have enough time for yourself?", "Do you feel your health has suffered because of your involvement with your Elder?," "Do you feel that your social life has suffered because you are caring for your Elder?", "Do you feel that you will be unable to take care of your Elder much longer?", "Do you feel you have lost control of your life since your Elder's illness?", "Do you feel very tired as a result of caring for your Elder?", "Do you feel isolated and alone as a result of caring for your Elder?", "Taking care of my Elder gives me a trapped feeling", and "I can fit in most of the things I need to do in spite of the time taken by caring for my Elder". The five-point Likert scale responses ranged from "never" to "nearly always." The score ranges from 5 to 45; higher score indicates greater burden
6 months
Score on Montgomery Objective Burden Scale
Periodo de tiempo: 6 months
The Montgomery Caregiving Objective Burden Scale consists of 6 items. Caregivers are asked if caregiving responsibilities have "decreased time you have to yourself", "given you little time for friends and relatives", "caused your social like to suffer", "changed your routine", "left you with almost no time to relax", and "kept you from recreational activities". Items were rated on a five point Likert scale ranging from "not at all" to "a great deal". The score ranges from 5 to 30; Higher score indicates greater burden
6 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de marzo de 2014

Finalización primaria (Actual)

1 de septiembre de 2016

Finalización del estudio (Actual)

1 de octubre de 2016

Fechas de registro del estudio

Enviado por primera vez

19 de marzo de 2014

Primero enviado que cumplió con los criterios de control de calidad

19 de marzo de 2014

Publicado por primera vez (Estimar)

20 de marzo de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

9 de julio de 2021

Última actualización enviada que cumplió con los criterios de control de calidad

8 de julio de 2021

Última verificación

1 de septiembre de 2020

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • AAAM5150
  • 7160 (Otro identificador: Patient-Centered outcomes Research Institute)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir